Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Binap, (A+-)- | HCID 634876 | — |
| Reactant | Tert-butyl 1,4-diazepane-1-carboxylate | HCID 2756058 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Reactant | HCID 118431708 | HCID 118431708 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | HCID 118431849 | HCID 118431849 | 40.6% |
Reaction Steps
5-(4-Bromo-phenyl)-1-(2,4-difluoro-phenyl)-3-[di-(trifluoromethyl)-hydroxy-methyl]-4,5-dihydro-1H-pyrazole (500.0 mg, 0.99 mmol) prepared in Step 2 of Preparation 22, 1-BOC-homopiperazine (235.0 uL, 1.19 mmol), Pd2(dba)3 (45.0 mg, cat.), BINAP (62.0 mg, cat.) and sodium t-butoxide (143.0 mg, 1.49 mmol) were added to toluene (10.0 mL). The reaction mixture was stirred at 100° C. for 12 hours and filtered through celite pad. A saturated solution of ammonium chloride was added to the filtrate, which was then extracted with ethyl acetate three times. The combined extract was washed with brine, dried on anhydrous magnesium sulfate, and then concentrated under reduced pressure to give a yellow liquid residue. The resulting residue was purified by silica gel column chromatography (eluent: ethyl acetate/n-hexane=1/5) to give 250.0 mg of the titled compound as a yellow liquid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09376420B2 |
|---|
| Source dataset | uspto-grants-2016_06 |
|---|
| ORD ID | ord-3a162c506aad4045b3a6f6d344280ea6 |
|---|
| Source note | uspto-grants-2016_06 |
|---|